Table 2 Expression of genes related to EMT after TGFβ and TNFα treatment

From: EMT is associated with an epigenetic signature of ECM remodeling genes

Gene

Protein

Cells

p Value

Up/down

Fold

Marker

CDH1

E-CADHERIN

A549

1.6E−6

Down

250

Epithelial

ACHN

0.007

Down

105

MCF10A

8.1E−4

Down

2.6

EPCAM

EPCAM

A549

0.001

Down

14

Epithelial

ACHN

0.001

Down

2.8

MCF10A

1.7E−4

Down

32

CDH2

N-CADHERIN

A549

3.9E−4

Up

5.2

Mesenchymal

ACHN

0.001

Up

2.0

MCF10A

1.8E−4

Up

6.3

VIM

VIMENTIN

A549

0.003

Up

2.0

Mesenchymal

ACHN

  

MCF10A

  

ZEB1

ZEB1

A549

1.6E−4

Up

2.6

EMT-ATF

ACHN

  

MCF10A

0.001

Up

3.8

ZEB2

ZEB1

A549

6.3E−4

Up

2.8

EMT-ATF

ACHN

  

MCF10A

0,001

Up

2.8

SNAI1

SNAIL1

A549

3.1E−5

Up

2.8

EMT-ATF

ACHN

  

MCF10A

2.0E-4

Up

7.0

A549

0.0010

Down

2.4

Epithelial

OCLN

OCCUDIN

ACHN

  

MCF10A

  

ETS1

ETS1

A549

2.1E−5

Up

3.2

Mesenchymal

ACHN

0.0024

Up

2.5

MCF10A

2.7E−5

Up

11.85

FN1

FIBRONECTIN

A549

2.2E−4

Up

11.7

Mesenchymal

ACHN

  

MCF10A

0.0091

Up

68.4

SDC1

SYNDECAN-1

A549

3.0E−5

Up

2.8

Mesenchymal

ACHN

  

MCF10A

  

SNAI2

SLUG

A549

3.5E−6

Up

17.6

EMT-ATF

ACHN

  

MCF10A

  
  1. List of genes issued from microarrays analysis (n = 4) in A549, ACHN, or MCF10A cells. p Value and fold change are indicated for each cell line. Epithelial markers (CDH1, EPCAM, OCLN, SDC1), mesenchymal markers (CDH2, VIMENTIN, ETS1, FN1), and EMT-ATFs (ZEB1, ZEB2, SNAI1, SNAI2) were analyzed
  2. EMT epithelial–mesenchymal transition, TGFβ transforming growth factor beta, TNFα tumor necrosis factor alpha